Skip to main content

Arbutus Biopharma Corp SC TO-I/A, filed Sep 30, 2026

Arbutus Biopharma Corp (ABUS)

Arbutus expects to purchase 46,000,000 Shares at US$5.00 per Share for an aggregate US$230 million, representing approximately 23% of issued and outstanding Shares; the offer was oversubscribed, so tendered shares will be prorated. AI summary

SC TO-I/A 2026-09-30
View Original
Added on October 18, 2026